These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32440207)

  • 1. Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression.
    Lin K; Chen H; Su C; Zhu H; Lai C; Shi Y
    Cancer Manag Res; 2020; 12():3091-3097. PubMed ID: 32440207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA TTN-AS1 Promotes the Proliferation and Invasion of Colorectal Cancer Cells by Activating miR-497-Mediated PI3K/Akt/mTOR Signaling.
    Cui Z; Han B; Wang X; Li Z; Wang J; Lv Y
    Onco Targets Ther; 2019; 12():11531-11539. PubMed ID: 31920341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
    Zhou Y; Zhang Z; Wo M; Xu W
    Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis.
    Qin J; Zhu T; Wu W; Chen H; He Y
    Onco Targets Ther; 2021; 14():393-402. PubMed ID: 33469315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
    Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
    Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA TTN-AS1 Regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression.
    Feng H; Wang Q; Xiao W; Zhang B; Jin Y; Lu H
    Onco Targets Ther; 2020; 13():4799-4811. PubMed ID: 32547107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TTN-AS1 contributes to gastric cancer progression by acting as a competing endogenous RNA of miR-376b-3p.
    Dong MM; Peng SJ; Yuan YN; Luo HP
    Neoplasma; 2019 Jul; 66(4):564-575. PubMed ID: 30943745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
    Zhong L; Zhong X
    Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis in prostatic cancer by sponging miR-193a-5p.
    Luo JF; Xu J; Zheng JZ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7816-7825. PubMed ID: 31599406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.
    He H; Wang N; Yi X; Tang C; Wang D
    Cell Biosci; 2017; 7():65. PubMed ID: 29214011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of the Long Non-Coding RNA TTN-AS1 Attenuates the Malignant Progression of Osteosarcoma Cells by Regulating the miR-16-1-3p/TFAP4 Axis.
    Meng X; Zhang Z; Chen L; Wang X; Zhang Q; Liu S
    Front Oncol; 2021; 11():652835. PubMed ID: 34141611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
    Huang Y; Chu P; Bao G
    Dig Dis Sci; 2021 Nov; 66(11):3916-3928. PubMed ID: 33387127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
    Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
    Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.
    Lin Z; Li Y; Shao R; Hu Y; Gao H
    World J Surg Oncol; 2021 Jun; 19(1):163. PubMed ID: 34090483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA TTN-AS1 promotes breast cancer cell migration and invasion via sponging miR-140-5p.
    Xue J; Zhang Z; Li X; Ren Q; Wang Q
    Oncol Lett; 2020 Feb; 19(2):1255-1260. PubMed ID: 31966055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TTN-AS1 promotes the progression of cholangiocarcinoma via the miR-320a/neuropilin-1 axis.
    Zhu H; Zhai B; He C; Li Z; Gao H; Niu Z; Jiang X; Lu J; Sun X
    Cell Death Dis; 2020 Aug; 11(8):637. PubMed ID: 32801339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
    Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
    Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis.
    Fu SW; Zhang Y; Li S; Shi ZY; Zhao J; He QL
    Cancer Cell Int; 2020; 20():415. PubMed ID: 32863773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
    Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.